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Abstract
Artemisia roxburghiana is used in traditional medicine for treating various diseases including
diabetes. The present study was designed to evaluate the antidiabetic potential of active
constituents by using protein tyrosine phosphatase 1B (PTP1B) as a validated target for
management of diabetes. Various compounds were isolated as active principles from the crude
methanolic extract of aerial parts of A. roxburghiana. All compounds were screened for PTP1B
inhibitory activity. Molecular docking simulations were performed to investigate the mechan-
ism behind PTP1B inhibition of the isolated compound and positive control, ursolic acid.
Betulinic acid, betulin and taraxeryl acetate were the active PTP1B principles with IC50 values
3.49 ± 0.02, 4.17 ± 0.03 and 87.52 ± 0.03 mM, respectively. Molecular docking studies showed
significant molecular interactions of the triterpene inhibitors with Gly220, Cys215, Gly218 and
Asp48 inside the active site of PTP1B. The antidiabetic activity of A. roxburghiana could be
attributed due to PTP1B inhibition by its triterpene constituents, betulin, betulinic acid and
taraxeryl acetate. Computational insights of this study revealed that the C-3 and C-17 positions
of the compounds needs extensive optimization for the development of new lead compounds.
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Introduction
Protein tyrosine phosphatases (PTPs) are enzymes that play
pivotal role in cellular processes, such as cell growth, proliferation
and differentiation. Several recent studies further revealed that
PTPs are involved in various metabolic activities, immunological
responses, cell-cell adhesions and cell-matrix interactions1–3.
Protein tyrosine phosphatase 1B (PTP1B), is an intracellular non-
receptor type PTP, which is considered to be a well-validated
therapeutic target for many diseases including diabetes. Extensive
biochemical and genetic investigations have shown that PTP1B is
involved in the negative control of insulin- and leptin-receptor4–6.
Other evidence from PTP1B-knockout mice further revealed an
increased sensitivity to insulin, enhanced glycemic control and
resistant to diet-induced obesity7. Hence, inhibition of PTP1B
offers a novel approach in regulating type-2 diabetes and obesity.
Accordingly, researches in many laboratories worldwide are
currently focusing in the search of novel PTP1B inhibitors from
synthesis and natural sources.
Artemisia roxburghiana Besser is a perennial aromatic herb
belonging to the family Asteraceae. In Pakistan, where the plant
is native and occupying dry open slopes and waste lands of the
Himalayan region, various ethnobotanical uses have been
reported. These include for treating fever, rheumatism, malaria,
dysentery and hepatitis8,9. The aerial parts are also used to treat
diabetes either alone or in combination with other plants, such as
the dried fruits of Zizyphus jujube9. In support of this latter
traditional use, the ethanolic extract of A. roxburghiana from
Pakistan has previously shown to display insulin secretagogue
activity in cultured insulinoma cell line, INS-1 cells10. Apart from
preliminary phytochemical studies, such as essential oils analysis
by GC-MS9–11, the active antidiabetic principles of the plants
have not yet been investigated. Owing to the prominent role of
PTP1B in diabetes, we herewith identified the active components
of A. roxburghiana using this pharmacological target. Through
molecular docking simulation studies, we have also shown, for
the first time, the molecular mechanism of PTP1B inhibition
by the isolated compounds and the standard positive control,
ursolic acid.
Experimental
General phytochemical analysis methodology
1H NMR, 13C NMR and 2D-NMR (COSY, NOESY, HMQC and
HMBC experiments) spectra were obtained on a Bruker 600 MHz
instrument (Billerica, MA). Homonuclear 1H connectivities were
determined by using the COSY experiment. One bond 1H–13C
connectivities were determined with HMQC while two- and three-
bond 1H–13C connectivities were determined by HMBC
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experiments, as reported earlier. Chemical shifts were reported in
d (ppm) using the solvent (CD3OD) standard and coupling
constants (J) were measured in Hz. A Jeol JMS HX 110 mass
spectrometer (Tokyo, Japan) using glycerol as the matrix was
used for mass spectrometry. HREI MS was carried out on Jeol
JMS 600 mass spectrometer (Tokyo, Japan). Silica gel 60
(Merck, Darmstadt, Germany) was used as an adsorbent for open
column chromatography. TLC analysis was routinely performed
using hexane:EtOAc mixtures as the mobile phase and com-
pounds were visualized under UV light.
Plant material
The aerial parts (green stems with leaves) of A. roxburghiana
were collected from the University campus of Hazara University
Mansehra, Pakistan. The authenticated voucher specimen (no.
3486) was then deposited at the Herbarium of Hazara University,
Mansehra, Pakistan. The plant materials were shade dried and
ground into powder.
Extraction and isolation
The powdered plant materials (17 kg) were extracted three times
by soaking with 24 L of methanol for two weeks. Combined
extracts were filtered and evaporated under reduced pressure to
yield 1.5 kg of the crude extract. Preliminary fractionation of the
crude extract was done by suspending the crude extract in water
and extraction using solvents of increasing polarity:hexane
(4.2 L), chloroform (7.8 L), ethyl acetate (6 L) and n-butanol
(3 L). Remaining unfractionated crude extract was taken as
aqueous fraction. The ethyl acetate fraction (160 g) that showed
the highest PTP1B inhibitory activity was subjected to silica gel
column chromatography (CC, 700 mm 80 mm) with hexane
containing increasing percentage of ethyl acetate used as eluents.
Fractions obtained from the 4.0:6.0 to 0:10 hexane:EtOAc
mixtures were further subjected to CC under the same conditions
to yield six compounds: apigenin-7,4-dimethyl ether (1, 48.4 mg,
RF 0.56 in hexane:ethyl acetate 8.5:1.5); taraxeryl acetate (2,
271 mg, RF 0.75 in hexane:ethyl acetate 0.5:9.5); 9 mg of a
compound which was identified as betulin (3, 94 mg, RF 0.72 in
hexane:ethyl acetate 0.8:9.2); betulinic acid (4, 9.3 mg, RF 0.75 in
hexane:ethyl acetate 0.8:9.2); 7-Hydroxy-6-methoxy-coumarin
(Scopoletin, 5, 42 mg, RF 0.5 in hexane:ethyl acetate 1:9), and
6,7-dimethoxy-coumarin (6, 5 mg, RF 0.57 in hexane:ethyl acetate
1:9). The structures of all the isolated compounds were confirmed
by comparing their corresponding NMR and mass spectral data
with those previously reported12–17.
PTP1B inhibitory activity
The enzyme inhibition assay was carried out in 96-well plates
using 3,3-dimethyl glutarate buffer (pH 7.0). The reaction mixture
contained various concentrations of test drugs, p-nitrophenol
phosphate (pNPP, 1 mM) and PTB1B (10 mM). After incubation
at 27 C for 40 min, the absorbance of the released pNPP was
measured at 405 nm. All assays were carried out in triplicates
from which IC50 values were calculated.
Molecular docking simulations
OEDocking 3.0.0 (Santa Fe, NM)18–22 was used in this study to
dock the OMEGA pre-generated multi-conformer library. FRED
strategy was used, which exhaustively dock/score all possible
positions of each ligand in the binding site. The exhaustive search
is based on rigid rotations and translations of each conformer
within the binding site defined by a box. FRED filtered the poses
ensemble by rejecting the ones that clash with the protein
(PTP1B) or that does not have enough contacts with the protein.
The final poses can then be scored or re-scored using one or more
scoring functions. In this study, the smooth shape-based Gaussian
scoring function (shapegauss) was selected to evaluate the shape
complementarily between each ligand and the binding pocket.
Default FRED protocol was used except for the size of the
box defining the binding sites. In an attempt to optimize the
docking-scoring performance, we performed exhaustive docking
with shapegauss applying the ‘‘Optimization’’ mode. The
‘‘Optimization’’ mode involves a systematic solid body opti-
mization of the top ranked poses from the exhaustive docking.
Three different boxes were explored for PTP1B (PDB:2BGD).
Three different simulations were carried out with an added value
of 8 A˚ around the reference ligand. This method was validated
using the comparison of docked pose of the reference compound
in PDB file versus its crystal structure. RMSD values was found
to be 0.466, which seems to quite satisfactory.
Results and discussion
Apart from some preliminary studies showing the in vitro insulin
secretagogue activity A. roxburghiana10, scientific data to justify
the antidiabetic traditional uses of the plant is not available. In the
present study, PTP1B inhibitory activity was used as a validated
target for sourcing potentially useful antidiabetic compounds from
the plant. In this in vitro assay, the crude extract showed
considerable (59.2 ± 0.11%) enzyme inhibitory activity at the
concentration of 100lg/mL. In order to isolate the active PTP1B
inhibitory principles of the plant, the crude extract was
fractionated with solvents of increasing polarity. When screened
at the fixed concentration of 100lg/mL, the most active fraction
was ethyl acetate that displayed 68.2 ± 0.13% activity followed by
the crude extract (52.6 ± 0.18%), chloroform (46.3 ± 0.14%),
aqueous (42.1 ± 0.09), n-butanol (39.4 ± 0.12) and n-hexane
(21.7 ± 0.11%). Repetitive column chromatography over silica
gel of the most active ethyl acetate fraction afforded six
compounds, which were identified as apigenin-7,4-dimethyl
ether (1); taraxeryl acetate (2); betulin (3); betulinic acid (4);
7-hydroxy-6-methoxy-coumarin (Scopoletin, 5) and 6,7-
dimethoxy-coumarin (6, Figure 1). The spectral data of these
previously known compounds from other sources were in good
agreement with those published before by various authors12–17.
All of the isolated compounds together with the positive control,
ursolic acid, were subjected to PTP1B inhibition assay. The
relative activity of these compounds is shown in Table 1.
Ursolic acid is a pentacyclic triterpenoid acid that is commonly
used as a standard PTP1B inhibitory agent. The activity of this
standard positive control recorded in the present study (Table 1)
was in good agreement with those reported for the compound
previously17,23. Betulinic acid is another pentacyclic triterpene in
which hydroxyl and carboxyl groups located at similar positions
but differ from ursolic acid in one of the ring system (5-membered
ring in betulinic acid, Figure 1). Hence, betulinic acid, as with
previous reports24, displayed potent PTP1B inhibitory activity
(Table 1). The considerable role of the carboxylic acid moiety of
betulinic acid was demonstrated as its replacement by hydroxyl
moiety as in 3 (betulin) resulted in a slight decrease in activity by
approximately 25%. Similarly, compound 2 (taraxeryl acetate),
which lacks both the hydroxyl and carboxylic acid moieties was
over many fold less active than betulinic acid (4, Table 1).
In comparison to the triterpene compounds, the flavonoid (1) and
coumarins (5, 6) derivatives isolated from the active ethyl acetate
fraction did not show any activity. Since, some of the compounds
identified in the present study were known to occur in
A. roxburghiana25, our study appears to be the first report on
the identification of active compounds against PTP1B principles
of the plant. The antidiabetic effect of betulinic acid could also be
mediated through other effects including inhibition of pancreatic
lipase and adipocyte lipolysis26 and also by enhancing glucose
uptake in adipocytes after long treatment27. The PTP1B inhibitory
effect of betulin has not been reported before but it is known to
improve hyperlipidemia and insulin resistance in experimental
animals28.
Ursolic acid and its derivatives are reported with significant
PTP1B inhibitory activities. Through this mechanism, they are
known to enhance insulin receptor phosphorylation and stimulate
glucose uptake23. Mechanism and molecular modeling studies of
ursolic acid against PTP1B enzyme has been reported29. The
mechanism of interaction of these compounds (other than ursolic
acid) with PTP1B, however, has not yet been established. In the
present study, molecular docking analysis was employed to reveal
the favorable binding interactions between the enzyme and
triterpene inhibitors. Hydrogen bonding, dipole-dipole attractive
forces, hydrophobic interactions and certain other molecular
interactions are commonly found and investigated in ligand-
protein complexes, which contributes to strengthening, such as
macromolecular interactions29–34. The secondary hydroxyl group
of betulin (17-OH) showed significant and multiple bonding
interactions with important amino acid residues of PTP1B
(Figures 2 and 3). Interestingly, the amino and secondary amide
groups of Gly218, were found to be held by two hydrogen
Figure 1. Chemical structures of the isolated
compounds (1–6) and ursolic acid (7).
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Table 1. PTP1B activity of A. roxburghiana compounds and ursolic
acid*.
Compound IC50 values (mM)
1. Apigenin-7,4-dimethyl ether NA
2. Taraxeryl acetate 87.52 ± 0.03
3. Betulin 4.17 ± 0.03
4. Betulinic acid 3.49 ± 0.02
5. Scopoletin NA
6. 6,7-Dimethoxy-coumarin NA
7. Ursolic acid (reference) 3.21 ± 0.02
NA: Not active up to the concentration of 100 mM (give the highest
tested).
*Data are mean and SEM values from three separate experiments.
bonding interactions of the 17-OH group, at a distance of 2.99 and
2.76 A˚, respectively. Similarly, Gly220 and Cys215 were found to
interact through hydrogen bonding at a distance of 2.97 and
2.72 A˚, respectively. The other hydroxyl group at C-3 position
also played a critical role in protein-ligand complex through
hydrogen bonding with Asp48 (2.76 A˚): a terminal amino acid
residue lining the outer rim of active site of PTP1B. Apart from
polar interactions, favorable hydrophobic interactions were
detected between Val49 and the two methyl groups of the
triterpene skeleton at C-8 and C-10 positions. On the opposite
side, Phe182 was favorably supported by interaction with the
methyl group at C-14 position. Ile219 also exhibited hydrophobic
interactions with cyclic carbons at C-15 and C-16 positions.
Molecular shape and electrostatic behavior (Figure 4) of betulin
seems to be a major factor responsible for its potent inhibitory
activity. Molecular binding modes and interactions of betulinic
acid was almost the same as that of betulin (Figure 5). Carboxylic
acid group produced slight increase in inhibitory effect of
betulinic acid in comparison to betulin.
Most of the molecular interactions for ursolic acid were also
similar with betulin and betulinic acid. Few additional hydrogen
bonding interactions were, however, found of which the
carboxylic acid moiety played a critical role. The conformation
of ring E of ursolic acid made it favorable for the carboxylic acid
group to interact with Arg 221 (3.021 A˚) and Ser 216 (2.753 A˚)
via hydrogen bonding (Figures 6 and 7). This finding was in
agreement with the finding of taraxeryl acetate that lacks a
carboxylic acid moiety, with considerably weaker PTP1B
inhibitory activity (Table 1). The lack of C-3 hydroxyl group in
taraxeryl acetate that would have engaged in hydrogen bonding
interaction with Asp48 is a further reason for its weaker PTP1B
inhibitory activity.
The overall antidiabetic effect of A. roxburghiana could be
attributed to multiple effects including the present finding of
PTP1B inhibition, insulin secretagogue activity10 and other
effects reported for the active ingredients, betulin and betulinic
acid25–27. Experimental data obtained from our computational
insights study further revealed that the C-3 hydroxyl and C-17
Figure 3. A closer view of betulin bound to the active site of PTP13.
Figure 4. Electrostatic surface of PTP1B. Blue color indicates positive
electrostatic surface, red color region indicates negative electrostatic
surface and white region depicts non-polar (hydrophobic) surface of the
enzyme.
Figure 2. Molecular binding mode of betulin inside catalytic site of
PTP13. Hydrogen atoms (except polar ones) were omitted for clarity.
Figure 5. Similar binding modes of betulin and betulic acid. Both poses
of the compounds seems to be superimposed on each other. It clearly
depicts similar bonding interactions between the enzyme and inhibitors.
Figure 6. Molecular binding mode of ursolic acid inside active site of
PTP13.
carboxylic acid positions of the pentacyclic triterpene skeleton are
critical for designing new and better PTP1B inhibitors.
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Figure 7. A closer view of ursolic acid bound to the active site of PTP1B.
